Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. Februar 2026 16:05 ET | Quelle: Vaxcyte, Inc.

Vaxcyte Announces Closing of $632.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN CARLOS, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the closing of its previously announced underwritten...
29. Januar 2026 23:33 ET | Quelle: Vaxcyte, Inc.

Vaxcyte Announces Pricing of $550 Million Public Offering

SAN CARLOS, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the pricing of an underwritten public offering of...
23. Januar 2026 17:00 ET | Quelle: Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

SOUTH SAN FRANCISCO, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the closing of an upsized...
21. Januar 2026 23:18 ET | Quelle: Axogen, Inc.

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of...
21. Januar 2026 22:53 ET | Quelle: Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the pricing of an upsized...
21. Januar 2026 16:09 ET | Quelle: Axogen, Inc.

Axogen Announces Proposed Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of...
20. Januar 2026 16:01 ET | Quelle: Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that it has commenced an...
20. Januar 2026 09:50 ET | Quelle: BNP Paribas Primary New Issues

BNP Paribas Primary New Issues: POST STAB Notice - NO STAB - ContourGlobal

[20/01/2026] Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. CONTOURGLOBAL Post-stabilisation Period...
19. Januar 2026 06:15 ET | Quelle: Research and Markets

MEA Healthcare Factoring Market to Soar to USD 15.99 Billion by 2033

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "MEA Healthcare Factoring Services Market Size, Share & Trends Analysis Report by Category, Type (Recourse, Non-recourse), Application, Country with...
14. Januar 2026 07:00 ET | Quelle: LXP Industrial Trust

LXP Industrial Trust Closes on $600 Million Unsecured Revolving Credit Facility and $250 Million Unsecured Term Loan

WEST PALM BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- LXP Industrial Trust (“LXP”) (NYSE:LXP), a real estate investment trust focused on Class A warehouse and distribution real estate...

Vorherige Seite

Nächste Seite